Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 AZN | AstraZeneca PLC | $289.5b | $184.04 | +1.4% | 686.2K |
 TMO | Thermo Fisher Scientific, Inc. | $174.7b | $440.52 | +0.5% | 963.5K |
 DHR | Danaher Corporation | $126.7b | $164.07 | +1.3% | 1.4M |
 WAT | Waters Corp | $29.5b | $334.01 | +1.5% | 401.1K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $13.5b | $64.34 | -2.7% | 1.7M |
 GH | Guardant Health, Inc. Common Stock | $10.9b | $94.82 | -0.1% | 570.4K |
 RVTY | Revvity, Inc. | $9.5b | $96.20 | +2.4% | 317.1K |
 TEM | Tempus AI, Inc. Class A Common Stock | $9.2b | $43.69 | -0.5% | 3.9M |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $9.0b | $315.92 | -7.8% | 156.1K |
 TECH | Bio-Techne Corp. | $8.4b | $44.60 | +3.0% | 2.1M |
 NUVL | Nuvalent, Inc. Class A Common Stock | $8.0b | $99.48 | -2.8% | 240.9K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.8b | $79.72 | -3.0% | 326.4K |
 LNTH | Lantheus Holdings, Inc | $5.4b | $93.28 | -0.7% | 622.1K |
 CAI | Caris Life Sciences, Inc. Common Stock | $5.2b | $15.46 | +6.2% | 3.3M |
 TWST | Twist Bioscience Corporation Common Stock | $3.6b | $50.32 | +2.3% | 611.9K |
 DYN | Dyne Therapeutics, Inc. Common Stock | $3.0b | $16.71 | -3.4% | 655.4K |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $2.6b | $28.16 | -0.2% | 425.7K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $2.2b | $12.67 | -1.3% | 818.8K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $1.9b | $42.27 | +3.7% | 868.8K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.4b | $24.60 | -3.8% | 357.5K |
 CDNA | CareDx, Inc. | $1.1b | $20.36 | +1.9% | 411.7K |
 ANRO | Alto Neuroscience Inc. | $0.9b | $21.94 | -4.5% | 279.9K |
 CSTL | Castle Biosciences, Inc. Common Stock | $0.7b | $19.74 | +3.2% | 216.7K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.6b | $3.58 | +5.3% | 809.4K |
 AURA | Aura Biosciences, Inc. Common Stock | $446.8m | $7.47 | -3.5% | 520.2K |
 LAB | Standard BioTools Inc. Common Stock | $360.1m | $1.00 | +1.4% | 772.3K |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $358.3m | $4.72 | +2.0% | 31.3K |
 PRLD | Prelude Therapeutics Incorporated | $355.7m | $4.43 | -1.1% | 313.3K |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $327.8m | $2.46 | -1.8% | 384.5K |
 AVXL | Anavex Life Sciences | $312.3m | $2.88 | -1.0% | 525.3K |
 ACIU | AC Immune SA | $308.4m | $2.83 | +1.6% | 134.5K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $303.5m | $3.79 | 0.0% | 145.3K |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $240.4m | $10.44 | -5.5% | 116.2K |
 OABI | OmniAb, Inc. Common Stock | $202.7m | $2.25 | +3.0% | 843.0K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $197.3m | $0.83 | -6.5% | 3.1M |
 QTRX | Quanterix Corporation Common Stock | $157.2m | $2.55 | -7.3% | 899.3K |
 SEER | Seer, Inc. Class A Common Stock | $108.9m | $1.70 | -1.4% | 215.1K |
 MDXH | MDxHealth SA Ordinary Shares | $104.8m | $0.86 | -4.1% | 864.9K |
 BDSX | Biodesix, Inc. Common Stock | $100.6m | $14.49 | +2.3% | 17.1K |
 CSBR | Champions Oncology, Inc. | $82.1m | $6.11 | -1.5% | 6.2K |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $77.5m | $1.71 | -0.8% | 26.0K |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $73.6m | $1.68 | -5.4% | 360.1K |
 XGN | Exagen Inc. Common Stock | $65.9m | $3.45 | -5.2% | 271.0K |
 IBIO | iBio, Inc. Common Stock | $58.9m | $1.46 | -1.0% | 396.2K |
 CCEL | Cryo-Cell International Inc. | $28.0m | $3.50 | -3.5% | 5.3K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $27.0m | $8.84 | +11.2% | 10.0K |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $21.7m | $1.48 | +9.3% | 130.2K |
 ADVB | Advanced Biomed Inc. Common Stock | $7.2m | $4.16 | -5.6% | 4.6K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $5.1m | $1.36 | -12.3% | 125.6K |